Stock AnalizCelanese Corp CE
Major Chemicals · IPO 2005 · data as of November 13, 2026
Celanese Corp (CE) is a industrial company listed in the US with a market value of about $5.6B. In the twelve months to September 30, 2026 it had revenue of $9.8B and net income of $262M, a net margin of 2.7%.
Its overall Stock Analiz score is 1.8 out of 5 (weak). The strongest part is value (4/5); the weakest is future growth (0/5).
Key numbers: a P/E of 21.7, a price to free cash flow of 7.1, 5-year revenue growth of 11% a year, a 5-year average ROIC of 5%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 37% above the current price.
Score: 1.8 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- 5-year revenue growth above 8% a year
- Positive free cash flow
- Pays a dividend
- Dividend 3 years in a row
Checks not passed
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.8B | $9.5B | $10.3B | $10.9B | $9.7B | $8.5B | $5.7B | $6.3B | $7.2B | $6.1B | $5.4B |
| Net income | $262M | -$1.2B | -$1.5B | $1.9B | $1.9B | $1.9B | $2.0B | $852M | $1.2B | $843M | $900M |
| Free cash flow | $794M | $803M | $531M | $1.3B | $1.3B | $1.3B | $979M | $1.1B | $1.2B | $536M | $647M |
| EPS (diluted) | $2.37 | $-10.64 | $-14.11 | $17.76 | $17.34 | $16.86 | $16.75 | $6.84 | $8.91 | $6.09 | $6.18 |
| Net margin | 2.7% | -12.2% | -15.0% | 17.8% | 19.6% | 22.1% | 35.1% | 13.5% | 16.9% | 13.7% | 16.7% |
| ROIC | — | -4.3% | -3.1% | 6.2% | 5.2% | 19.7% | 7.9% | 11.0% | 16.5% | 10.5% | 14.7% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 18 analysts is $63.39, 23% above the current price; targets range from $52.00 to $86.00; the consensus rating is “Buy”; expected EPS is $6.17 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Celanese’s P/E ratio?
About 21.7, based on the last twelve months of diluted earnings per share (forward P/E about 9.2).
Is Celanese stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 37% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Celanese pay a dividend?
Yes. The dividend yield is about 0.23%, and it has paid dividends for 10 years in our data.
Is Celanese a good stock to buy?
We do not give buy or sell advice. Celanese scores 1.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.